Hosenkoside K exhibits significant anti-inflammatory activity, making it a candidate for development in treatments targeting chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines such as TNF-α and IL-6, which play central roles in conditions like arthritis and inflammatory bowel disease. Additionally, it shows moderate antioxidant properties, helping to reduce oxidative stress in cellular models. Research also suggests potential neuroprotective effects due to its ability to cross the blood-brain barrier and modulate signaling pathways involved in neuronal survival. These properties position Hosenkoside K as a lead compound in the development of natural product-derived therapeutics for neurodegenerative and inflammatory disorders.